{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:41:11Z","timestamp":1775760071669,"version":"3.50.1"},"reference-count":210,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:p>\n                    <jats:italic>Context.<\/jats:italic>\n                    \u2014Changes in reimbursements for clinical laboratory testing may help us assess the effect of various variables, such as testing recommendations, market forces, changes in testing technology, and changes in clinical or laboratory practices, and provide information that can influence health care and public health policy decisions. To date, however, there has been no report, to our knowledge, of longitudinal trends in national laboratory test use.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Objective.<\/jats:italic>\n                    \u2014To evaluate Medicare Part B\u2013reimbursed volumes of selected laboratory tests per 10\u2009000 enrollees from 2000 through 2010.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Design.<\/jats:italic>\n                    \u2014Laboratory test reimbursement volumes per 10\u2009000 enrollees in Medicare Part B were obtained from the Centers for Medicare &amp; Medicaid Services (Baltimore, Maryland). The ratio of the most recent (2010) reimbursed test volume per 10\u2009000 Medicare enrollees, divided by the oldest data (usually 2000) during this decade, called the\n                    <jats:italic>volume ratio<\/jats:italic>\n                    , was used to measure trends in test reimbursement. Laboratory tests with a reimbursement claim frequency of at least 10 per 10\u2009000 Medicare enrollees in 2010 were selected, provided there was more than a 50% change in test reimbursement volume during the 2000\u20132010 decade. We combined the reimbursed test volumes for the few tests that were listed under more than one code in the Current Procedural Terminology (American Medical Association, Chicago, Illinois). A 2-sided Poisson regression, adjusted for potential overdispersion, was used to determine\n                    <jats:italic>P<\/jats:italic>\n                    values for the trend; trends were considered significant at\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .05.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results.<\/jats:italic>\n                    \u2014Tests with the greatest decrease in reimbursement volumes were electrolytes, digoxin, carbamazepine, phenytoin, and lithium, with volume ratios ranging from 0.27 to 0.64 (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .001). Tests with the greatest increase in reimbursement volumes were meprobamate, opiates, methadone, phencyclidine, amphetamines, cocaine, and vitamin D, with volume ratios ranging from 83 to 1510 (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .001).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions.<\/jats:italic>\n                    \u2014Although reimbursement volumes increased for most of the selected tests, other tests exhibited statistically significant downward trends in annual reimbursement volumes. The observed changes in reimbursement volumes may be explained by disease prevalence and severity, patterns of drug use, clinical or laboratory practices, and testing recommendations and guidelines, among others. These data may be useful to policy makers, health systems researchers, laboratory directors, and industry scientists to understand, address, and anticipate trends in laboratory testing in the Medicare population.\n                  <\/jats:p>","DOI":"10.5858\/arpa.2013-0149-oa","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T18:50:58Z","timestamp":1370458258000},"page":"189-203","source":"Crossref","is-referenced-by-count":34,"title":["Trends in Laboratory Test Volumes for Medicare Part B Reimbursements, 2000\u20132010"],"prefix":"10.5858","volume":"138","author":[{"given":"Shahram","family":"Shahangian","sequence":"first","affiliation":[{"name":"From the Division of Laboratory Programs, Standards, and Services, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Shahangian and Astles and Messrs Yesupriya and Alspach);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd D.","family":"Alspach","sequence":"additional","affiliation":[{"name":"From the Division of Laboratory Programs, Standards, and Services, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Shahangian and Astles and Messrs Yesupriya and Alspach);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Rex","family":"Astles","sequence":"additional","affiliation":[{"name":"From the Division of Laboratory Programs, Standards, and Services, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Shahangian and Astles and Messrs Yesupriya and Alspach);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Yesupriya","sequence":"additional","affiliation":[{"name":"From the Division of Laboratory Programs, Standards, and Services, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Shahangian and Astles and Messrs Yesupriya and Alspach);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K.","family":"Dettwyler","sequence":"additional","affiliation":[{"name":"and Codus Medicus Inc, Salem, Oregon (Mr Dettwyler)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"issue":"8","key":"i1543-2165-138-2-189-b01","series-title":"Arch Pathol Lab Med","first-page":"1201","article-title":"National Inventory of Clinical Laboratory Testing Services (NICLTS): development and test distribution for 1996","volume":"124","author":"Steindel\n              SJ,","year":"2000","unstructured":"Steindel\n              SJ, \n            \n              Rauch\n              WJ, \n            \n              Simon\n              MK, \n            \n              Handsfield\n              J. \n          \n          National Inventory of Clinical Laboratory Testing Services (NICLTS): development and test distribution for 1996. Arch Pathol Lab Med. 2000;124(8):1201\u20131208."},{"issue":"suppl 1","key":"i1543-2165-138-2-189-b02","series-title":"Clin Infect Dis","first-page":"S36","article-title":"Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response","volume":"52","author":"Jernigan\n              DB,","year":"2011","unstructured":"Jernigan\n              DB, \n            \n              Lindstrom\n              SL, \n            \n              Johnson\n              JR, \n            et al\n          . Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis. 2011;52(suppl 1):S36\u2013S43."},{"issue":"8","key":"i1543-2165-138-2-189-b03","series-title":"Blood Coagul Fibrinolysis","first-page":"688","article-title":"Reducing the use of coagulation test panels","volume":"22","author":"Amukele\n              TK,","year":"2011","unstructured":"Amukele\n              TK, \n            \n              Baird\n              GS, \n            \n              Chandler\n              WL. \n          \n          Reducing the use of coagulation test panels. Blood Coagul Fibrinolysis. 2011;22(8):688\u2013695."},{"issue":"1","key":"i1543-2165-138-2-189-b04","series-title":"Int J Technol Assess Health Care","first-page":"30","article-title":"Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: a health technology assessment report","volume":"26","author":"Schnell-Inderst\n              P,","year":"2010","unstructured":"Schnell-Inderst\n              P, \n            \n              Schwarzer\n              R, \n            \n              G\u00f6hler\n              A, \n            et al\n          . Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: a health technology assessment report. Int J Technol Assess Health Care. 2010;26(1):30\u201339."},{"issue":"7","key":"i1543-2165-138-2-189-b05","series-title":"Ann Intern Med","first-page":"474","article-title":"Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement","volume":"151","year":"2009","unstructured":"US Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(7):474\u2013482."},{"issue":"2","key":"i1543-2165-138-2-189-b06","series-title":"Clin Chem","first-page":"378","article-title":"NACB LMPG Committee Members. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease","volume":"55","author":"Myers\n              GL,","year":"2009","unstructured":"Myers\n              GL, \n            \n              Christenson\n              RH, \n            \n              Cushman\n              M, \n            et al;\n          \n          NACB LMPG Committee Members. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem. 2009;55(2):378\u2013384."},{"issue":"6","key":"i1543-2165-138-2-189-b07","series-title":"Age Ageing","first-page":"655","article-title":"The accuracy of plasma natriuretic peptide levels for diagnosis of cardiac dysfunction and chronic heart failure in community-dwelling elderly: a systematic review","volume":"38","author":"Vaes\n              B,","year":"2009","unstructured":"Vaes\n              B, \n            \n              de Ruijter\n              W, \n            \n              Gussekloo\n              J, \n            \n              Degryse\n              J. \n          \n          The accuracy of plasma natriuretic peptide levels for diagnosis of cardiac dysfunction and chronic heart failure in community-dwelling elderly: a systematic review. Age Ageing. 2009;38(6):655\u2013662."},{"issue":"18","key":"i1543-2165-138-2-189-b08","series-title":"Arch Intern Med","first-page":"1978","article-title":"A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure","volume":"164","author":"Doust\n              JA,","year":"2004","unstructured":"Doust\n              JA, \n            \n              Glasziou\n              PP, \n            \n              Pietrzak\n              E, \n            \n              Dobson\n              AJ. \n          \n          A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med. 2004;164(18):1978\u20131984."},{"issue":"12","key":"i1543-2165-138-2-189-b09","series-title":"Clin Chem","first-page":"2086","article-title":"NACB Writing Group, NACB Committee. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure","volume":"53","author":"Wu\n              AH,","year":"2007","unstructured":"Wu\n              AH, \n            \n              Jaffe\n              AS, \n            \n              Apple\n              FS, \n            et al;\n          \n          NACB Writing Group, NACB Committee. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem. 2007;53(12):2086\u20132096."},{"issue":"12","key":"i1543-2165-138-2-189-b10","series-title":"Clin Cardiol","first-page":"723","article-title":"A review of causes and systemic approach to cardiac troponin elevation","volume":"34","author":"Patil\n              H,","year":"2011","unstructured":"Patil\n              H, \n            \n              Vaidya\n              O, \n            \n              Bogart\n              D. \n          \n          A review of causes and systemic approach to cardiac troponin elevation. Clin Cardiol. 2011;34(12):723\u2013728."},{"issue":"2","key":"i1543-2165-138-2-189-b11","series-title":"Am J Emerg Med","first-page":"162","article-title":"EMCREG i*trACS Investigators. Outcomes associated with small changes in normal-range cardiac markers","volume":"29","author":"McMullin\n              N,","year":"2011","unstructured":"McMullin\n              N, \n            \n              Lindsell\n              CJ, \n            \n              Lei\n              L, \n            et al;\n          \n          EMCREG i*trACS Investigators. Outcomes associated with small changes in normal-range cardiac markers. Am J Emerg Med. 2011;29(2):162\u2013167."},{"issue":"2","key":"i1543-2165-138-2-189-b12","series-title":"Eur J Cardiothorac Surg","first-page":"399","article-title":"The prognostic value of troponin release after adult cardiac surgery\u2014a meta-analysis","volume":"37","year":"2010","unstructured":"Lurati Buse GA, Koller MT, Grapow M, Bolliger D, Seeberger M, Filipovic M. The prognostic value of troponin release after adult cardiac surgery\u2014a meta-analysis. Eur J Cardiothorac Surg. 2010;37(2):399\u2013406."},{"issue":"13","key":"i1543-2165-138-2-189-b13","series-title":"Circulation","first-page":"e356","article-title":"National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes","volume":"115","author":"Morrow\n              DA,","year":"2007","unstructured":"Morrow\n              DA, \n            \n              Cannon\n              CP, \n            \n              Jesse\n              RL, \n            et al;\n          \n          National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115(13):e356\u2013e375."},{"issue":"suppl 2","key":"i1543-2165-138-2-189-b14","series-title":"J Inherit Metab Dis","first-page":"S225","article-title":"Newborn screening strategies for congenital hypothyroidism: an update","volume":"33","author":"LaFranchi\n              SH.","year":"2010","unstructured":"LaFranchi\n              SH. \n          \n          Newborn screening strategies for congenital hypothyroidism: an update. J Inherit Metab Dis. 2010;33(suppl 2):S225\u2013S233."},{"issue":"2","key":"i1543-2165-138-2-189-b15","series-title":"Ann Intern Med","first-page":"128","article-title":"US Preventative Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"140","author":"Helfand\n              M;","year":"2004","unstructured":"Helfand\n              M; \n          \n          US Preventative Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(2):128\u2013141."},{"issue":"2","key":"i1543-2165-138-2-189-b16","series-title":"Endocrinol Metab Clin North Am","first-page":"245","article-title":"Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease","volume":"30","author":"Ross\n              DS.","year":"2001","unstructured":"Ross\n              DS. \n          \n          Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am. 2001;30(2):245\u2013264, vii."},{"issue":"3","key":"i1543-2165-138-2-189-b17","series-title":"Endocrinol Metab Clin North Am","first-page":"579","article-title":"Laboratory tests of thyroid function: uses and limitations","volume":"36","author":"Dufour\n              DR.","year":"2007","unstructured":"Dufour\n              DR. \n          \n          Laboratory tests of thyroid function: uses and limitations. Endocrinol Metab Clin North Am. 2007;36(3):579\u2013594, v."},{"issue":"7","key":"i1543-2165-138-2-189-b18","series-title":"Int J Clin Pract","first-page":"848","article-title":"Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus","volume":"64","author":"Jackson\n              G,","year":"2010","unstructured":"Jackson\n              G, \n            \n              Boon\n              N, \n            \n              Eardley\n              I, \n            et al\n          . Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract. 2010;64(7):848\u2013857."},{"issue":"2","key":"i1543-2165-138-2-189-b19","series-title":"Menopause Int","first-page":"87","article-title":"Testosterone therapy in men","volume":"15","author":"Theodoraki\n              A,","year":"2009","unstructured":"Theodoraki\n              A, \n            \n              Bouloux\n              PM. \n          \n          Testosterone therapy in men. Menopause Int. 2009;15(2):87\u201392."},{"key":"i1543-2165-138-2-189-b20","article-title":"Screening for cervical cancer: a decision analysis for the U.S. Preventive Services Task Force","author":"Kulasingam\n              SL,","year":"2011","unstructured":"Kulasingam\n              SL, \n            \n              Havrilesky\n              L, \n            \n              Ghebre\n              R, \n            \n              Myers\n              ER. \n          \n          Screening for cervical cancer: a decision analysis for the U.S. Preventive Services Task Force. 2011. http:\/\/www.ncbi.nlm.nih.gov\/books\/nbk92546\/pdf\/toc.pdf. Accessed January 8, 2014."},{"issue":"5","key":"i1543-2165-138-2-189-b21","series-title":"J Natl Cancer Inst","first-page":"368","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman\n              M,","year":"2011","unstructured":"Schiffman\n              M, \n            \n              Wentzensen\n              N, \n            \n              Wacholder\n              S, \n            \n              Kinney\n              W, \n            \n              Gage\n              JC, \n            \n              Castle\n              PE. \n          \n          Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 20112;103(5):368\u2013383."},{"issue":"5","key":"i1543-2165-138-2-189-b22","series-title":"Eur J Gynaecol Oncol","first-page":"351","article-title":"The current status of HPV DNA testing","volume":"24","author":"Agnantis\n              NJ,","year":"2003","unstructured":"Agnantis\n              NJ, \n            \n              Sotiriadis\n              A, \n            \n              Paraskevaidis\n              E. \n          \n          The current status of HPV DNA testing. Eur J Gynaecol Oncol. 2003;24(5):351\u2013356."},{"issue":"6","key":"i1543-2165-138-2-189-b23","series-title":"Am J Clin Oncol","first-page":"567","article-title":"19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy","volume":"34","author":"Hallemeier\n              CL,","year":"2011","unstructured":"Hallemeier\n              CL, \n            \n              Botros\n              M, \n            \n              Corsini\n              MM, \n            \n              Haddock\n              MG, \n            \n              Gunderson\n              LL, \n            \n              Miller\n              RC. \n            \n              Preoperative\n              CA\n            \n          \n          19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy. Am J Clin Oncol. 2011;34(6):567\u2013572."},{"issue":"6","key":"i1543-2165-138-2-189-b24","series-title":"Clin Chem","first-page":"e1","article-title":"National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers","volume":"56","author":"Sturgeon\n              CM,","year":"2010","unstructured":"Sturgeon\n              CM, \n            \n              Duffy\n              MJ, \n            \n              Hofmann\n              BR, \n            et al;\n          \n          National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem. 2010;56(6):e1\u2013e48."},{"issue":"3","key":"i1543-2165-138-2-189-b25","series-title":"Eur J Surg Oncol","first-page":"266","article-title":"Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer","volume":"33","author":"Goonetilleke\n              KS,","year":"2007","unstructured":"Goonetilleke\n              KS, \n            \n              Siriwardena\n              AK. \n          \n          Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33(3):266\u2013270."},{"issue":"33","key":"i1543-2165-138-2-189-b26","series-title":"J Clin Oncol","first-page":"5313","article-title":"ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker\n              GY,","year":"2006","unstructured":"Locker\n              GY, \n            \n              Hamilton\n              S, \n            \n              Harris\n              J, \n            et al;\n          \n          ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24(33):5313\u20135327."},{"issue":"2","key":"i1543-2165-138-2-189-b27","series-title":"Best Pract Res Clin Gastroenterol","first-page":"227","article-title":"Evidence-based diagnosis and staging of pancreatic cancer","volume":"20","author":"Michl\n              P,","year":"2006","unstructured":"Michl\n              P, \n            \n              Pauls\n              S, \n            \n              Gress\n              TM. \n          \n          Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20(2):227\u2013251."},{"issue":"7","key":"i1543-2165-138-2-189-b28","series-title":"J Clin Endocrinol Metab","first-page":"1911","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick\n              MF,","year":"2011","unstructured":"Holick\n              MF, \n            \n              Binkley\n              NC, \n            \n              Bischoff-Ferrari\n              HA, \n            et al\n          . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911\u20131930."},{"issue":"1020","key":"i1543-2165-138-2-189-b29","series-title":"Postgrad Med J","first-page":"608","article-title":"The cure of ageing: vitamin D\u2014magic or myth?","volume":"86","author":"Chu\n              MP,","year":"2010","unstructured":"Chu\n              MP, \n            \n              Alagiakrishnan\n              K, \n            \n              Sadowski\n              C. \n          \n          The cure of ageing: vitamin D\u2014magic or myth?\n          Postgrad Med J. 2010;86(1020):608\u2013616."},{"issue":"1","key":"i1543-2165-138-2-189-b30","series-title":"Curr Drug Targets","first-page":"54","article-title":"Vitamin D in atherosclerosis, vascular disease, and endothelial function","volume":"12","author":"Brewer\n              LC,","year":"2011","unstructured":"Brewer\n              LC, \n            \n              Michos\n              ED, \n            \n              Reis\n              JP. \n          \n          Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets. 2011;12(1):54\u201360."},{"issue":"RR-8","key":"i1543-2165-138-2-189-b31","series-title":"MMWR Recomm Rep","first-page":"1","article-title":"Centers for Disease Control and Prevention. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection","volume":"57","author":"Weinbaum\n              CM,","year":"2008","unstructured":"Weinbaum\n              CM, \n            \n              Williams\n              I, \n            \n              Mast\n              EE, \n            et al;\n          \n          Centers for Disease Control and Prevention. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1\u201320."},{"issue":"6","key":"i1543-2165-138-2-189-b32","series-title":"Clin Gastroenterol Hepatol","first-page":"666","article-title":"Chronic hepatitis B: current testing strategies","volume":"4","author":"Gish\n              RG,","year":"2006","unstructured":"Gish\n              RG, \n            \n              Locarnini\n              SA. \n          \n          Chronic hepatitis B: current testing strategies. Clin Gastroenterol Hepatol. 2006;4(6):666\u2013676."},{"issue":"RR-19","key":"i1543-2165-138-2-189-b33","series-title":"MMWR Recomm Rep","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease","volume":"47","year":"1998","unstructured":"Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1\u201339."},{"issue":"RR-4","key":"i1543-2165-138-2-189-b34","series-title":"MMWR Recomm Rep","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965","volume":"61","author":"Smith\n              BD,","year":"2012","unstructured":"Smith\n              BD, \n            \n              Morgan\n              RL, \n            \n              Beckett\n              GA, \n            et al\n          . Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965. MMWR Recomm Rep. 2012;61(RR-4):1\u201332."},{"issue":"6","key":"i1543-2165-138-2-189-b35","series-title":"Ann Intern Med","first-page":"465","article-title":"Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force","volume":"140","author":"Chou\n              R,","year":"2004","unstructured":"Chou\n              R, \n            \n              Clark\n              EC, \n            \n              Helfand\n              M. \n          \n          Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(6):465\u2013479."},{"issue":"1","key":"i1543-2165-138-2-189-b36","series-title":"Clin Lab Med","first-page":"311","article-title":"Lyme disease","volume":"30","author":"Murray\n              TS,","year":"2010","unstructured":"Murray\n              TS, \n            \n              Shapiro\n              ED. \n          \n          Lyme disease. Clin Lab Med. 2010;30(1):311\u2013328."},{"issue":"6","key":"i1543-2165-138-2-189-b37","series-title":"Anaerobe","first-page":"270","article-title":"Clostridium difficile testing algorithms: what is practical and feasible?","volume":"15","author":"Schmidt\n              ML,","year":"2009","unstructured":"Schmidt\n              ML, \n            \n              Gilligan\n              PH. \n          \n          Clostridium difficile testing algorithms: what is practical and feasible?\n          Anaerobe. 2009;15(6):270\u2013273."},{"issue":"3","key":"i1543-2165-138-2-189-b38","series-title":"J Postgrad Med","first-page":"194","article-title":"The utility of repeat enzyme immunoassay testing for the diagnosis of Clostridium difficile infection: a systematic review of the literature","volume":"58","author":"Garimella\n              PS,","year":"2012","unstructured":"Garimella\n              PS, \n            \n              Agarwal\n              R, \n            \n              Katz\n              A. \n          \n          The utility of repeat enzyme immunoassay testing for the diagnosis of Clostridium difficile infection: a systematic review of the literature. J Postgrad Med. 2012;58(3):194\u2013198."},{"issue":"1","key":"i1543-2165-138-2-189-b39","series-title":"Mayo Clin Proc","first-page":"66","article-title":"Urine drug screening: practical guide for clinicians","volume":"83","author":"Moeller\n              KE,","year":"2008","unstructured":"Moeller\n              KE, \n            \n              Lee\n              KC, \n            \n              Kissack\n              JC. \n          \n          Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83(1):66\u201376."},{"issue":"7520","key":"i1543-2165-138-2-189-b40","series-title":"BMJ","first-page":"810","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster\n              AC,","year":"2005","unstructured":"Webster\n              AC, \n            \n              Woodroffe\n              RC, \n            \n              Taylor\n              RS, \n            \n              Chapman\n              JR, \n            \n              Craig\n              JC. \n          \n          Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ. 2005;331(7520):810."},{"issue":"7191","key":"i1543-2165-138-2-189-b41","series-title":"BMJ","first-page":"1104","article-title":"Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials","volume":"318","author":"Knoll\n              GA,","year":"1999","unstructured":"Knoll\n              GA, \n            \n              Bell\n              RC. \n          \n          Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ. 1999;318(7191):1104\u20131107."},{"issue":"suppl 2","key":"i1543-2165-138-2-189-b42","series-title":"J Psychopharmacol","first-page":"17","article-title":"Lithium in maintenance therapy for bipolar disorder","volume":"20","author":"Young\n              AH,","year":"2006","unstructured":"Young\n              AH, \n            \n              Newham\n              JI. \n          \n          Lithium in maintenance therapy for bipolar disorder. J Psychopharmacol. 2006;20(suppl 2):17\u201322."},{"issue":"3","key":"i1543-2165-138-2-189-b43","series-title":"Eur Arch Psychiatry Clin Neurosci","first-page":"132","article-title":"Lithium augmentation therapy in refractory depression-update 2002","volume":"253","author":"Bauer\n              M,","year":"2003","unstructured":"Bauer\n              M, \n            \n              Forsthoff\n              A, \n            \n              Baethge\n              C, \n            et al\n          . Lithium augmentation therapy in refractory depression-update 2002. Eur Arch Psychiatry Clin Neurosci. 2003;253(3):132\u2013139."},{"issue":"3","key":"i1543-2165-138-2-189-b44","series-title":"Eur Arch Psychiatry Clin Neurosci","first-page":"115","article-title":"Lithium in the acute treatment of bipolar disorders\u2014a stocktaking","volume":"253","author":"Grunze\n              H.","year":"2003","unstructured":"Grunze\n              H. \n          \n          Lithium in the acute treatment of bipolar disorders\u2014a stocktaking. Eur Arch Psychiatry Clin Neurosci. 2003;253(3):115\u2013119."},{"issue":"2\u20133","key":"i1543-2165-138-2-189-b45","series-title":"J Affect Disord","first-page":"273","article-title":"Trends in lithium prescription in Spain from 1985 to 2003","volume":"91","author":"Castells\n              X,","year":"2006","unstructured":"Castells\n              X, \n            \n              Vallano\n              A, \n            \n              Rigau\n              D, \n            \n              Perez\n              J, \n            \n              Casas\n              M, \n            \n              Capella\n              D. \n          \n          Trends in lithium prescription in Spain from 1985 to 2003. J Affect Disord. 2006;91(2\u20133):273\u2013276."},{"issue":"6","key":"i1543-2165-138-2-189-b46","series-title":"Acta Neurol Scand","first-page":"405","article-title":"Trends in utilization of antiepileptic drugs in Denmark","volume":"113","author":"Tsiropoulos\n              I,","year":"2006","unstructured":"Tsiropoulos\n              I, \n            \n              Gichangi\n              A, \n            \n              Andersen\n              M, \n            \n              Bjerrum\n              L, \n            \n              Gaist\n              D, \n            \n              Hallas\n              J. \n          \n          Trends in utilization of antiepileptic drugs in Denmark. Acta Neurol Scand. 2006;113(6):405\u2013411."},{"issue":"1","key":"i1543-2165-138-2-189-b47","series-title":"Clin Pharmacol Ther","first-page":"90","article-title":"Declining public health burden of digoxin toxicity from 1991 to 2004","volume":"84","author":"Haynes\n              K,","year":"2008","unstructured":"Haynes\n              K, \n            \n              Heitjan\n              D, \n            \n              Kanetsky\n              P, \n            \n              Hennessy\n              S. \n          \n          Declining public health burden of digoxin toxicity from 1991 to 2004. Clin Pharmacol Ther. 2008;84(1):90\u201394."},{"issue":"10","key":"i1543-2165-138-2-189-b48","series-title":"J Am Acad Child Adolesc Psychiatry","first-page":"1001","article-title":"National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996\u20132007","volume":"49","author":"Comer\n              JS,","year":"2010","unstructured":"Comer\n              JS, \n            \n              Olfson\n              M, \n            \n              Mojtabai\n              R. \n          \n          National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996\u20132007. J Am Acad Child Adolesc Psychiatry. 2010;49(10):1001\u20131010."},{"issue":"6","key":"i1543-2165-138-2-189-b49","series-title":"Arch Dis Child","first-page":"443","article-title":"Changing trends in antiepileptic drug prescribing in girls of child-bearing potential","volume":"94","author":"Ackers\n              R,","year":"2009","unstructured":"Ackers\n              R, \n            \n              Besag\n              FM, \n            \n              Wade\n              A, \n            \n              Murray\n              ML, \n            \n              Wong\n              IC. \n          \n          Changing trends in antiepileptic drug prescribing in girls of child-bearing potential. Arch Dis Child. 2009;94(6):443\u2013447."},{"issue":"22, pt 2","key":"i1543-2165-138-2-189-b50","series-title":"Neurology","first-page":"2171","article-title":"Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000\u20132004","volume":"70","author":"Pugh\n              MJ,","year":"2008","unstructured":"Pugh\n              MJ, \n            \n              Van Cott\n              AC, \n            \n              Cramer\n              JA, \n            et al\n          . Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000\u20132004. Neurology. 2008;70(22, pt 2):2171\u20132178."},{"issue":"6","key":"i1543-2165-138-2-189-b51","series-title":"Seizure","first-page":"466","article-title":"Trends in antiepileptic drug utilisation in UK primary care 1993\u20132008: cohort study using the General Practice Research Database","volume":"21","author":"Nicholas\n              JM,","year":"2012","unstructured":"Nicholas\n              JM, \n            \n              Ridsdale\n              L, \n            \n              Richardson\n              MP, \n            \n              Ashworth\n              M, \n            \n              Gulliford\n              MC. \n          \n          Trends in antiepileptic drug utilisation in UK primary care 1993\u20132008: cohort study using the General Practice Research Database. Seizure. 2012;21(6):466\u2013470."},{"issue":"34","key":"i1543-2165-138-2-189-b52","series-title":"BMC Med","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-34","article-title":"Biomarkers in acute myocardial infarction","volume":"8","author":"Chan\n              D,","year":"2010","unstructured":"Chan\n              D, \n            \n              Ng\n              LL. \n          \n          Biomarkers in acute myocardial infarction. BMC Med. 2010;8:34. doi:10.1186\/1741-7015-8-34."},{"issue":"3","key":"i1543-2165-138-2-189-b53","series-title":"J Cardiol","first-page":"317","article-title":"Inflammatory biomarkers in coronary artery disease","volume":"53","author":"Zakynthinos\n              E,","year":"2009","unstructured":"Zakynthinos\n              E, \n            \n              Pappa\n              N. \n          \n          Inflammatory biomarkers in coronary artery disease. J Cardiol. 2009;53(3):317\u2013333."},{"issue":"4","key":"i1543-2165-138-2-189-b54","series-title":"Ther Adv Cardiovasc Dis","first-page":"309","article-title":"The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease","volume":"3","author":"Kones\n              R.","year":"2009","unstructured":"Kones\n              R. \n          \n          The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease. Ther Adv Cardiovasc Dis. 2009;3(4):309\u2013315."},{"issue":"1","key":"i1543-2165-138-2-189-b55","series-title":"Cardiovasc Pathol","first-page":"14","article-title":"C-reactive protein: a nontraditional serum marker of cardiovascular risk","volume":"16","author":"de Ferranti\n              SD,","year":"2007","unstructured":"de Ferranti\n              SD, \n            \n              Rifai\n              N. \n          \n          C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol. 2007;16(1):14\u201321."},{"issue":"2","key":"i1543-2165-138-2-189-b56","series-title":"Curr Atheroscler Rep","first-page":"154","article-title":"The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial","volume":"13","author":"Abd\n              TT,","year":"2011","unstructured":"Abd\n              TT, \n            \n              Eapen\n              DJ, \n            \n              Bajpai\n              A, \n            \n              Goyal\n              A, \n            \n              Dollar\n              A, \n            \n              Sperling\n              L. \n          \n          The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial. Curr Atheroscler Rep. 2011;13(2):154\u2013161."},{"issue":"4","key":"i1543-2165-138-2-189-b57","series-title":"Clin Cardiol","first-page":"190","article-title":"Should we measure C-reactive protein on earth or just on JUPITER?","volume":"33","author":"Bajpai\n              A,","year":"2010","unstructured":"Bajpai\n              A, \n            \n              Goyal\n              A, \n            \n              Sperling\n              L. \n          \n          Should we measure C-reactive protein on earth or just on JUPITER?\n          Clin Cardiol. 2010;33(4):190\u2013198."},{"issue":"4","key":"i1543-2165-138-2-189-b58","series-title":"AACN Clin Issues","first-page":"520","article-title":"The measurement of brain natriuretic peptide in heart failure: precision, accuracy, and implications for practice","volume":"14","author":"Howie\n              JN,","year":"2003","unstructured":"Howie\n              JN, \n            \n              Caldwell\n              MA, \n            \n              Dracup\n              K. \n          \n          The measurement of brain natriuretic peptide in heart failure: precision, accuracy, and implications for practice. AACN Clin Issues. 2003;14(4):520\u2013531."},{"issue":"4","key":"i1543-2165-138-2-189-b59","series-title":"Heart Fail Rev","first-page":"349","article-title":"The role of brain natriuretic peptide in population screening","volume":"8","author":"Dyrbye\n              LN,","year":"2003","unstructured":"Dyrbye\n              LN, \n            \n              Redfield\n              MM. \n          \n          The role of brain natriuretic peptide in population screening. Heart Fail Rev. 2003;8(4):349\u2013354."},{"issue":"4","key":"i1543-2165-138-2-189-b60","series-title":"Heart Fail Rev","first-page":"327","article-title":"The diagnosis of acute congestive heart failure: role of BNP measurements","volume":"8","author":"Maisel\n              AS.","year":"2003","unstructured":"Maisel\n              AS. \n          \n          The diagnosis of acute congestive heart failure: role of BNP measurements. Heart Fail Rev. 2003;8(4):327\u2013334."},{"issue":"4\u20135","key":"i1543-2165-138-2-189-b61","series-title":"Clin Biochem","first-page":"227","article-title":"Evaluating the evidence for assessing BNP and NT-proBNP levels","volume":"41","author":"Busse\n              JW,","year":"2008","unstructured":"Busse\n              JW, \n            \n              Bassler\n              D, \n            \n              Guyatt\n              GH. \n          \n          Evaluating the evidence for assessing BNP and NT-proBNP levels. Clin Biochem. 2008;41(4\u20135):227\u2013330."},{"issue":"4\u20135","key":"i1543-2165-138-2-189-b62","series-title":"Clin Biochem","first-page":"260","article-title":"A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease","volume":"41","author":"Oremus\n              M,","year":"2008","unstructured":"Oremus\n              M, \n            \n              Raina\n              PS, \n            \n              Santaguida\n              P, \n            et al\n          . A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clin Biochem. 2008;41(4\u20135):260\u2013265."},{"issue":"11","key":"i1543-2165-138-2-189-b63","series-title":"Clin Res Cardiol","first-page":"973","article-title":"Biomarkers: optimizing treatment guidance in heart failure","volume":"100","author":"Bohm\n              M,","year":"2011","unstructured":"Bohm\n              M, \n            \n              Voors\n              AA, \n            \n              Ketelslegers\n              JM, \n            et al\n          . Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol. 2011;100(11):973\u2013981."},{"issue":"12","key":"i1543-2165-138-2-189-b64","series-title":"Heart","first-page":"959","article-title":"Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis","volume":"97","author":"Kelder\n              JC,","year":"2011","unstructured":"Kelder\n              JC, \n            \n              Cowie\n              MR, \n            \n              McDonagh\n              TA, \n            et al\n          . Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis. Heart. 2011;97(12):959\u2013963."},{"issue":"2","key":"i1543-2165-138-2-189-b65","series-title":"Intern Med J","first-page":"101","article-title":"Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction","volume":"38","author":"Ewald\n              B,","year":"2008","unstructured":"Ewald\n              B, \n            \n              Ewald\n              D, \n            \n              Thakkinstian\n              A, \n            \n              Attia\n              J. \n          \n          Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction. Intern Med J. 2008;38(2):101\u2013113."},{"issue":"4\u20135","key":"i1543-2165-138-2-189-b66","series-title":"Clin Biochem","first-page":"240","article-title":"Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care","volume":"41","author":"Hill\n              SA,","year":"2008","unstructured":"Hill\n              SA, \n            \n              Balion\n              CM, \n            \n              Santaguida\n              P, \n            et al\n          . Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care. Clin Biochem. 2008;41(4\u20135):240\u2013249."},{"issue":"142","key":"i1543-2165-138-2-189-b67","series-title":"Evid Rep Technol Assess (Full Rep)","first-page":"1","article-title":"Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure","author":"Balion\n              C,","year":"2006","unstructured":"Balion\n              C, \n            \n              Santaguida\n              PL, \n            \n              Hill\n              S, \n            et al\n          . Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Evid Rep Technol Assess (Full Rep). 2006;(142):1\u2013147."},{"issue":"6","key":"i1543-2165-138-2-189-b68","series-title":"J Am Acad Nurse Pract","first-page":"226","article-title":"Thyroid disease: a review for primary care","volume":"12","author":"Larson\n              J,","year":"2000","unstructured":"Larson\n              J, \n            \n              Anderson\n              EH, \n            \n              Koslawy\n              M. \n          \n          Thyroid disease: a review for primary care. J Am Acad Nurse Pract. 2000;12(6):226\u2013232."},{"key":"i1543-2165-138-2-189-b69","series-title":"Syst Evid Rev","article-title":"Screening for thyroid disease","volume":"23","author":"Helfand\n              M.","year":"2004","unstructured":"Helfand\n              M. \n          \n          Screening for thyroid disease. 2004. Syst Evid Rev. 23. http:\/\/www.ncbi.nlm.nih.gov\/books\/nbk42812. Accessed January 8, 2014."},{"issue":"2","key":"i1543-2165-138-2-189-b70","series-title":"JAMA","first-page":"228","article-title":"Subclinical thyroid disease: scientific review and guidelines for diagnosis and management","volume":"291","author":"Surks\n              MI,","year":"2004","unstructured":"Surks\n              MI, \n            \n              Ortiz\n              E, \n            \n              Daniels\n              GH, \n            et al\n          . Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228\u2013238."},{"issue":"6","key":"i1543-2165-138-2-189-b71","series-title":"Clin Neuropharmacol","first-page":"248","article-title":"Thyroid adverse effects of psychotropic drugs: a review","volume":"34","year":"2011","unstructured":"Bou Khalil R, Richa S. Thyroid adverse effects of psychotropic drugs: a review. Clin Neuropharmacol. 2011;34(6):248\u2013255."},{"issue":"1\u20132","key":"i1543-2165-138-2-189-b72","series-title":"Clin Chim Acta","first-page":"111","article-title":"Case finding and screening strategies for thyroid dysfunction","volume":"315","author":"Stockigt\n              JR.","year":"2002","unstructured":"Stockigt\n              JR. \n          \n          Case finding and screening strategies for thyroid dysfunction. Clin Chim Acta. 2002;315(1\u20132):111\u2013124."},{"issue":"3","key":"i1543-2165-138-2-189-b73","series-title":"Compr Ther","first-page":"202","article-title":"Cervical cancer screening from Pap smear to human papillomavirus DNA testing","volume":"27","author":"Jin\n              XW,","year":"2001","unstructured":"Jin\n              XW, \n            \n              Xu\n              H. \n          \n          Cervical cancer screening from Pap smear to human papillomavirus DNA testing. Compr Ther. 2001;27(3):202\u2013208."},{"issue":"1","key":"i1543-2165-138-2-189-b74","series-title":"Clin Microbiol Rev","first-page":"1","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd\n              EM.","year":"2003","unstructured":"Burd\n              EM. \n          \n          Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1\u201317."},{"issue":"2","key":"i1543-2165-138-2-189-b75","series-title":"Best Pract Res Clin Obstet Gynaecol","first-page":"209","article-title":"Human papillomavirus deoxyribonucleic acid testing in developed countries","volume":"26","author":"Bhatla\n              N,","year":"2012","unstructured":"Bhatla\n              N, \n            \n              Singla\n              S, \n            \n              Awasthi\n              D. \n          \n          Human papillomavirus deoxyribonucleic acid testing in developed countries. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):209\u2013220."},{"issue":"11","key":"i1543-2165-138-2-189-b76","series-title":"Clin Chem Lab Med","first-page":"1783","article-title":"Human papilloma virus (HPV) molecular diagnostics","volume":"49","author":"Kroupis\n              C,","year":"2011","unstructured":"Kroupis\n              C, \n            \n              Vourlidis\n              N. \n          \n          Human papilloma virus (HPV) molecular diagnostics. Clin Chem Lab Med. 2011;49(11):1783\u20131799."},{"issue":"4","key":"i1543-2165-138-2-189-b77","series-title":"Cancer Cytopathol","first-page":"219","article-title":"Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology","volume":"119","author":"Nishino\n              HT,","year":"2011","unstructured":"Nishino\n              HT, \n            \n              Tambouret\n              RH, \n            \n              Wilbur\n              DC. \n          \n          Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology. Cancer Cytopathol. 2011;119(4):219\u2013227."},{"issue":"1","key":"i1543-2165-138-2-189-b78","series-title":"Eur J Cancer Prev","first-page":"73","article-title":"Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30: systematic review","volume":"21","author":"Rebolj\n              M,","year":"2012","unstructured":"Rebolj\n              M, \n            \n              Njor\n              SH, \n            \n              Lynge\n              E. \n          \n          Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30: systematic review. Eur J Cancer Prev. 2012;21(1):73\u201381."},{"issue":"3","key":"i1543-2165-138-2-189-b79","series-title":"Sex Health","first-page":"376","article-title":"Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era","volume":"7","author":"Tota\n              J,","year":"2010","unstructured":"Tota\n              J, \n            \n              Mahmud\n              SM, \n            \n              Ferenczy\n              A, \n            \n              Coutlee\n              F, \n            \n              Franco\n              EL. \n          \n          Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era. Sex Health. 2010;7(3):376\u2013382."},{"issue":"2","key":"i1543-2165-138-2-189-b80","series-title":"Curr Gastroenterol Rep","first-page":"131","article-title":"New developments in pancreatic cancer","volume":"13","author":"Greer\n              JB,","year":"2011","unstructured":"Greer\n              JB, \n            \n              Brand\n              RE. \n          \n          New developments in pancreatic cancer. Curr Gastroenterol Rep. 2011;13(2):131\u2013139."},{"issue":"4\u20135","key":"i1543-2165-138-2-189-b81","series-title":"Dig Dis","first-page":"679","article-title":"What's new in therapy of pancreatic cancer?","volume":"28","author":"Mossner\n              J.","year":"2010","unstructured":"Mossner\n              J. \n          \n          What's new in therapy of pancreatic cancer?\n          Dig Dis. 2010;28(4\u20135):679\u2013683."},{"issue":"4","key":"i1543-2165-138-2-189-b82","series-title":"Oncology","first-page":"255","article-title":"Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer","volume":"70","author":"Boeck\n              S,","year":"2006","unstructured":"Boeck\n              S, \n            \n              Stieber\n              P, \n            \n              Holdenrieder\n              S, \n            \n              Wilkowski\n              R, \n            \n              Heinemann\n              V. \n          \n          Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer. Oncology. 2006;70(4):255\u2013264."},{"issue":"6","key":"i1543-2165-138-2-189-b83","series-title":"JOP","first-page":"536","article-title":"Molecular and clinical markers of pancreas cancer","volume":"11","author":"Buxbaum\n              JL,","year":"2010","unstructured":"Buxbaum\n              JL, \n            \n              Eloubeidi\n              MA. \n          \n          Molecular and clinical markers of pancreas cancer. JOP. 2010;11(6):536\u2013544."},{"issue":"6","key":"i1543-2165-138-2-189-b84","series-title":"Langenbecks Arch Surg","first-page":"883","article-title":"Molecular markers of pancreatic cancer: development and clinical relevance","volume":"393","author":"Fry\n              LC,","year":"2008","unstructured":"Fry\n              LC, \n            \n              Monkemuller\n              K, \n            \n              Malfertheiner\n              P. \n          \n          Molecular markers of pancreatic cancer: development and clinical relevance. Langenbecks Arch Surg. 2008;393(6):883\u2013890."},{"key":"i1543-2165-138-2-189-b85","article-title":"Surveillance, epidemiology and end results: cancer of pancreas. 2012","unstructured":"National Cancer Institute. Surveillance, epidemiology and end results: cancer of pancreas. 2012. http:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html#prevalence. Accessed January 8, 2014."},{"issue":"1","key":"i1543-2165-138-2-189-b86","series-title":"J Clin Endocrinol Metab","first-page":"53","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross\n              AC,","year":"2011","unstructured":"Ross\n              AC, \n            \n              Manson\n              JE, \n            \n              Abrams\n              SA, \n            et al\n          . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53\u201358."},{"issue":"suppl 5","key":"i1543-2165-138-2-189-b87","series-title":"Hepatology","first-page":"S35","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection","volume":"49","author":"Weinbaum\n              CM,","year":"2009","unstructured":"Weinbaum\n              CM, \n            \n              Mast\n              EE, \n            \n              Ward\n              JW. \n          \n          Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology. 2009;49(suppl 5):S35\u2013S44."},{"issue":"suppl 1","key":"i1543-2165-138-2-189-b88","series-title":"Clin Infect Dis","first-page":"S49","article-title":"Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update","volume":"55","author":"Smith\n              BD,","year":"2012","unstructured":"Smith\n              BD, \n            \n              Jorgensen\n              C, \n            \n              Zibbell\n              JE, \n            \n              Beckett\n              GA. \n          \n          Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update. Clin Infect Dis. 2012;55(suppl 1):S49\u2013S53."},{"issue":"11","key":"i1543-2165-138-2-189-b89","series-title":"Am Fam Physician","first-page":"1351","article-title":"Hepatitis C: diagnosis and treatment","volume":"81","author":"Wilkins\n              T,","year":"2010","unstructured":"Wilkins\n              T, \n            \n              Malcolm\n              JK, \n            \n              Raina\n              D, \n            \n              Schade\n              RR. \n          \n          Hepatitis C: diagnosis and treatment. Am Fam Physician. 2010;81(11):1351\u20131357."},{"key":"i1543-2165-138-2-189-b90","article-title":"Lyme disease data. 2012","unstructured":"Centers for Disease Control and Prevention. Lyme disease data. 2012. http:\/\/www.cdc.gov\/lyme\/stats\/index.html?utm_source=publish2&utm_medium=referral&utm_campaign=www.kpbs.org. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b91","article-title":"Influenza\u2014United States surveillance data: 1997\u20131998 through 2009\u20132010 seasons. 2010","unstructured":"Centers for Disease Control and Prevention. Influenza\u2014United States surveillance data: 1997\u20131998 through 2009\u20132010 seasons. 2010. http:\/\/www.cdc.gov\/flu\/weekly\/ussurvdata.htm. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b92","series-title":"Cochrane Database Syst Rev","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003961.pub2","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients","author":"Webster\n              A,","year":"2005","unstructured":"Webster\n              A, \n            \n              Woodroffe\n              RC, \n            \n              Taylor\n              RS, \n            \n              Chapman\n              JR, \n            \n              Craig\n              JC. \n          \n          Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev. 2005;(4):CD003961. doi: 10.1002\/14651858.CD003961.pub2."},{"issue":"1","key":"i1543-2165-138-2-189-b93","series-title":"Arch Intern Med","first-page":"55","article-title":"Stafford RS, Ruskin JN, Singer DE. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation","volume":"164","author":"Fang\n              MC,","year":"2004","unstructured":"Fang\n              MC, \n          \n          Stafford RS, Ruskin JN, Singer DE. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med. 2004;164(1):55\u201360."},{"issue":"71","key":"i1543-2165-138-2-189-b94","series-title":"Fed Regist","first-page":"19644","article-title":"Mandatory guidelines and proposed revisions to mandatory guidelines for federal workplace drug testing programs; notices","volume":"69","year":"2004","unstructured":"Department of Health and Human Services. Mandatory guidelines and proposed revisions to mandatory guidelines for federal workplace drug testing programs; notices. Fed Regist. 2004;69(71):19644\u201319673."},{"issue":"83","key":"i1543-2165-138-2-189-b95","series-title":"Fed Regist","first-page":"22809","article-title":"Mandatory guidelines for federal workplace drug testing programs","volume":"75","year":"2010","unstructured":"Department of Health and Human Services. Mandatory guidelines for federal workplace drug testing programs. Fed Regist. 2010;75(83):22809\u201322810."},{"key":"i1543-2165-138-2-189-b96","article-title":"Guidelines. 2012","unstructured":"American Society of Interventional Pain Physicians. Guidelines. 2012. http:\/\/www.asipp.org\/Guidelines.htm. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b97","article-title":"Interagency guideline on opioid dosing for non-cancer pain: an educational aid to improve care and safety with opioid therapy. 2010","unstructured":"Agency Medical Doctors Group. Interagency guideline on opioid dosing for non-cancer pain: an educational aid to improve care and safety with opioid therapy. 2010. http:\/\/www.agencymeddirectors.wa.gov\/files\/opioidgdline.pdf. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b98","article-title":"Prescription painkiller overdoses","unstructured":"Centers for Disease Control and Prevention. Prescription painkiller overdoses. http:\/\/www.cdc.gov\/vitalsigns\/methadoneoverdoses. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b99","article-title":"National Center for Injury Prevention and Control program report","year":"2012","unstructured":"Centers for Disease Control and Prevention. National Center for Injury Prevention and Control program report. 2012."},{"key":"i1543-2165-138-2-189-b100","series-title":"CAP Today","article-title":"Probing the nuances of pain management","author":"Lusky\n              K.","unstructured":"Lusky\n              K. \n          \n          Probing the nuances of pain management. CAP Today. April 2009.http:\/\/www.cap.org\/apps\/cap.portal?_nfpb=true&cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&_windowLabel=cntvwrPtlt&cntvwrPtlt%7BactionForm.contentReference%7D=cap_today%2F0409%2F0409b_pain_management.html&_state=maximized&_pageLabel=cntvwr. Accessed January 8, 2014."},{"issue":"3","key":"i1543-2165-138-2-189-b101","series-title":"J Pain Symptom Manage","first-page":"260","article-title":"Urine drug testing in pain medicine","volume":"27","author":"Heit\n              HA,","year":"2004","unstructured":"Heit\n              HA, \n            \n              Gourlay\n              DL. \n          \n          Urine drug testing in pain medicine. J Pain Symptom Manage. 2004;27(3):260\u2013267."},{"issue":"1","key":"i1543-2165-138-2-189-b102","series-title":"Pain Physician","first-page":"57","article-title":"Does adherence monitoring reduce controlled substance abuse in chronic pain patients?","volume":"9","author":"Manchikanti\n              L,","year":"2006","unstructured":"Manchikanti\n              L, \n            \n              Manchukonda\n              R, \n            \n              Damron\n              KS, \n            \n              Brandon\n              D, \n            \n              McManus\n              CD, \n            \n              Cash\n              K. \n          \n          Does adherence monitoring reduce controlled substance abuse in chronic pain patients?\n          Pain Physician. 2006;9(1):57\u201360."},{"key":"i1543-2165-138-2-189-b103","article-title":"Urine drug testing and monitoring in pain management. 2006","author":"Fornari\n              FA,","unstructured":"Fornari\n              FA, \n            \n              Siwicki\n              DM, \n            \n              Bauer\n              GB. \n          \n          Urine drug testing and monitoring in pain management. 2006. https:\/\/www.dominiondiagnostics.com\/docs\/pubs\/0607DominionPub_UDTinPainManagement.pdf. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b104","article-title":"Drug abuse warning network, 2009: national estimates of drug-related emergency department visits","year":"2011","unstructured":"Substance Abuse and Mental Health Services Administration. Drug abuse warning network, 2009: national estimates of drug-related emergency department visits. 2011. http:\/\/www.samhsa.gov\/data\/2k11\/dawn\/2k9dawned\/html\/dawn2k9ed.htm. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b105","article-title":"2012. Part B: national summary data file (previously known as BESS)","unstructured":"Centers for Medicare & Medicaid Services. 2012. Part B: national summary data file (previously known as BESS). http:\/\/www.cms.gov\/research-statistics-data-and-systems\/files-for-order\/nonIdentifiabledatafiles\/partbnationalsummarydatafile.html. Accessed January 8, 2014."},{"issue":"8","key":"i1543-2165-138-2-189-b01","series-title":"Arch Pathol Lab Med","first-page":"1201","article-title":"National Inventory of Clinical Laboratory Testing Services (NICLTS): development and test distribution for 1996","volume":"124","author":"Steindel\n              SJ,","year":"2000","unstructured":"Steindel\n              SJ, \n            \n              Rauch\n              WJ, \n            \n              Simon\n              MK, \n            \n              Handsfield\n              J. \n          \n          National Inventory of Clinical Laboratory Testing Services (NICLTS): development and test distribution for 1996. Arch Pathol Lab Med. 2000;124(8):1201\u20131208."},{"issue":"suppl 1","key":"i1543-2165-138-2-189-b02","series-title":"Clin Infect Dis","first-page":"S36","article-title":"Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response","volume":"52","author":"Jernigan\n              DB,","year":"2011","unstructured":"Jernigan\n              DB, \n            \n              Lindstrom\n              SL, \n            \n              Johnson\n              JR, \n            et al\n          . Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis. 2011;52(suppl 1):S36\u2013S43."},{"issue":"8","key":"i1543-2165-138-2-189-b03","series-title":"Blood Coagul Fibrinolysis","first-page":"688","article-title":"Reducing the use of coagulation test panels","volume":"22","author":"Amukele\n              TK,","year":"2011","unstructured":"Amukele\n              TK, \n            \n              Baird\n              GS, \n            \n              Chandler\n              WL. \n          \n          Reducing the use of coagulation test panels. Blood Coagul Fibrinolysis. 2011;22(8):688\u2013695."},{"issue":"1","key":"i1543-2165-138-2-189-b04","series-title":"Int J Technol Assess Health Care","first-page":"30","article-title":"Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: a health technology assessment report","volume":"26","author":"Schnell-Inderst\n              P,","year":"2010","unstructured":"Schnell-Inderst\n              P, \n            \n              Schwarzer\n              R, \n            \n              G\u00f6hler\n              A, \n            et al\n          . Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: a health technology assessment report. Int J Technol Assess Health Care. 2010;26(1):30\u201339."},{"issue":"7","key":"i1543-2165-138-2-189-b05","series-title":"Ann Intern Med","first-page":"474","article-title":"Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement","volume":"151","year":"2009","unstructured":"US Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(7):474\u2013482."},{"issue":"2","key":"i1543-2165-138-2-189-b06","series-title":"Clin Chem","first-page":"378","article-title":"NACB LMPG Committee Members. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease","volume":"55","author":"Myers\n              GL,","year":"2009","unstructured":"Myers\n              GL, \n            \n              Christenson\n              RH, \n            \n              Cushman\n              M, \n            et al;\n          \n          NACB LMPG Committee Members. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem. 2009;55(2):378\u2013384."},{"issue":"6","key":"i1543-2165-138-2-189-b07","series-title":"Age Ageing","first-page":"655","article-title":"The accuracy of plasma natriuretic peptide levels for diagnosis of cardiac dysfunction and chronic heart failure in community-dwelling elderly: a systematic review","volume":"38","author":"Vaes\n              B,","year":"2009","unstructured":"Vaes\n              B, \n            \n              de Ruijter\n              W, \n            \n              Gussekloo\n              J, \n            \n              Degryse\n              J. \n          \n          The accuracy of plasma natriuretic peptide levels for diagnosis of cardiac dysfunction and chronic heart failure in community-dwelling elderly: a systematic review. Age Ageing. 2009;38(6):655\u2013662."},{"issue":"18","key":"i1543-2165-138-2-189-b08","series-title":"Arch Intern Med","first-page":"1978","article-title":"A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure","volume":"164","author":"Doust\n              JA,","year":"2004","unstructured":"Doust\n              JA, \n            \n              Glasziou\n              PP, \n            \n              Pietrzak\n              E, \n            \n              Dobson\n              AJ. \n          \n          A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med. 2004;164(18):1978\u20131984."},{"issue":"12","key":"i1543-2165-138-2-189-b09","series-title":"Clin Chem","first-page":"2086","article-title":"NACB Writing Group, NACB Committee. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure","volume":"53","author":"Wu\n              AH,","year":"2007","unstructured":"Wu\n              AH, \n            \n              Jaffe\n              AS, \n            \n              Apple\n              FS, \n            et al;\n          \n          NACB Writing Group, NACB Committee. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem. 2007;53(12):2086\u20132096."},{"issue":"12","key":"i1543-2165-138-2-189-b10","series-title":"Clin Cardiol","first-page":"723","article-title":"A review of causes and systemic approach to cardiac troponin elevation","volume":"34","author":"Patil\n              H,","year":"2011","unstructured":"Patil\n              H, \n            \n              Vaidya\n              O, \n            \n              Bogart\n              D. \n          \n          A review of causes and systemic approach to cardiac troponin elevation. Clin Cardiol. 2011;34(12):723\u2013728."},{"issue":"2","key":"i1543-2165-138-2-189-b11","series-title":"Am J Emerg Med","first-page":"162","article-title":"EMCREG i*trACS Investigators. Outcomes associated with small changes in normal-range cardiac markers","volume":"29","author":"McMullin\n              N,","year":"2011","unstructured":"McMullin\n              N, \n            \n              Lindsell\n              CJ, \n            \n              Lei\n              L, \n            et al;\n          \n          EMCREG i*trACS Investigators. Outcomes associated with small changes in normal-range cardiac markers. Am J Emerg Med. 2011;29(2):162\u2013167."},{"issue":"2","key":"i1543-2165-138-2-189-b12","series-title":"Eur J Cardiothorac Surg","first-page":"399","article-title":"The prognostic value of troponin release after adult cardiac surgery\u2014a meta-analysis","volume":"37","year":"2010","unstructured":"Lurati Buse GA, Koller MT, Grapow M, Bolliger D, Seeberger M, Filipovic M. The prognostic value of troponin release after adult cardiac surgery\u2014a meta-analysis. Eur J Cardiothorac Surg. 2010;37(2):399\u2013406."},{"issue":"13","key":"i1543-2165-138-2-189-b13","series-title":"Circulation","first-page":"e356","article-title":"National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes","volume":"115","author":"Morrow\n              DA,","year":"2007","unstructured":"Morrow\n              DA, \n            \n              Cannon\n              CP, \n            \n              Jesse\n              RL, \n            et al;\n          \n          National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115(13):e356\u2013e375."},{"issue":"suppl 2","key":"i1543-2165-138-2-189-b14","series-title":"J Inherit Metab Dis","first-page":"S225","article-title":"Newborn screening strategies for congenital hypothyroidism: an update","volume":"33","author":"LaFranchi\n              SH.","year":"2010","unstructured":"LaFranchi\n              SH. \n          \n          Newborn screening strategies for congenital hypothyroidism: an update. J Inherit Metab Dis. 2010;33(suppl 2):S225\u2013S233."},{"issue":"2","key":"i1543-2165-138-2-189-b15","series-title":"Ann Intern Med","first-page":"128","article-title":"US Preventative Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"140","author":"Helfand\n              M;","year":"2004","unstructured":"Helfand\n              M; \n          \n          US Preventative Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(2):128\u2013141."},{"issue":"2","key":"i1543-2165-138-2-189-b16","series-title":"Endocrinol Metab Clin North Am","first-page":"245","article-title":"Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease","volume":"30","author":"Ross\n              DS.","year":"2001","unstructured":"Ross\n              DS. \n          \n          Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am. 2001;30(2):245\u2013264, vii."},{"issue":"3","key":"i1543-2165-138-2-189-b17","series-title":"Endocrinol Metab Clin North Am","first-page":"579","article-title":"Laboratory tests of thyroid function: uses and limitations","volume":"36","author":"Dufour\n              DR.","year":"2007","unstructured":"Dufour\n              DR. \n          \n          Laboratory tests of thyroid function: uses and limitations. Endocrinol Metab Clin North Am. 2007;36(3):579\u2013594, v."},{"issue":"7","key":"i1543-2165-138-2-189-b18","series-title":"Int J Clin Pract","first-page":"848","article-title":"Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus","volume":"64","author":"Jackson\n              G,","year":"2010","unstructured":"Jackson\n              G, \n            \n              Boon\n              N, \n            \n              Eardley\n              I, \n            et al\n          . Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract. 2010;64(7):848\u2013857."},{"issue":"2","key":"i1543-2165-138-2-189-b19","series-title":"Menopause Int","first-page":"87","article-title":"Testosterone therapy in men","volume":"15","author":"Theodoraki\n              A,","year":"2009","unstructured":"Theodoraki\n              A, \n            \n              Bouloux\n              PM. \n          \n          Testosterone therapy in men. Menopause Int. 2009;15(2):87\u201392."},{"key":"i1543-2165-138-2-189-b20","article-title":"Screening for cervical cancer: a decision analysis for the U.S. Preventive Services Task Force","author":"Kulasingam\n              SL,","year":"2011","unstructured":"Kulasingam\n              SL, \n            \n              Havrilesky\n              L, \n            \n              Ghebre\n              R, \n            \n              Myers\n              ER. \n          \n          Screening for cervical cancer: a decision analysis for the U.S. Preventive Services Task Force. 2011. http:\/\/www.ncbi.nlm.nih.gov\/books\/nbk92546\/pdf\/toc.pdf. Accessed January 8, 2014."},{"issue":"5","key":"i1543-2165-138-2-189-b21","series-title":"J Natl Cancer Inst","first-page":"368","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman\n              M,","year":"2011","unstructured":"Schiffman\n              M, \n            \n              Wentzensen\n              N, \n            \n              Wacholder\n              S, \n            \n              Kinney\n              W, \n            \n              Gage\n              JC, \n            \n              Castle\n              PE. \n          \n          Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 20112;103(5):368\u2013383."},{"issue":"5","key":"i1543-2165-138-2-189-b22","series-title":"Eur J Gynaecol Oncol","first-page":"351","article-title":"The current status of HPV DNA testing","volume":"24","author":"Agnantis\n              NJ,","year":"2003","unstructured":"Agnantis\n              NJ, \n            \n              Sotiriadis\n              A, \n            \n              Paraskevaidis\n              E. \n          \n          The current status of HPV DNA testing. Eur J Gynaecol Oncol. 2003;24(5):351\u2013356."},{"issue":"6","key":"i1543-2165-138-2-189-b23","series-title":"Am J Clin Oncol","first-page":"567","article-title":"19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy","volume":"34","author":"Hallemeier\n              CL,","year":"2011","unstructured":"Hallemeier\n              CL, \n            \n              Botros\n              M, \n            \n              Corsini\n              MM, \n            \n              Haddock\n              MG, \n            \n              Gunderson\n              LL, \n            \n              Miller\n              RC. \n            \n              Preoperative\n              CA\n            \n          \n          19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy. Am J Clin Oncol. 2011;34(6):567\u2013572."},{"issue":"6","key":"i1543-2165-138-2-189-b24","series-title":"Clin Chem","first-page":"e1","article-title":"National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers","volume":"56","author":"Sturgeon\n              CM,","year":"2010","unstructured":"Sturgeon\n              CM, \n            \n              Duffy\n              MJ, \n            \n              Hofmann\n              BR, \n            et al;\n          \n          National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem. 2010;56(6):e1\u2013e48."},{"issue":"3","key":"i1543-2165-138-2-189-b25","series-title":"Eur J Surg Oncol","first-page":"266","article-title":"Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer","volume":"33","author":"Goonetilleke\n              KS,","year":"2007","unstructured":"Goonetilleke\n              KS, \n            \n              Siriwardena\n              AK. \n          \n          Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33(3):266\u2013270."},{"issue":"33","key":"i1543-2165-138-2-189-b26","series-title":"J Clin Oncol","first-page":"5313","article-title":"ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker\n              GY,","year":"2006","unstructured":"Locker\n              GY, \n            \n              Hamilton\n              S, \n            \n              Harris\n              J, \n            et al;\n          \n          ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24(33):5313\u20135327."},{"issue":"2","key":"i1543-2165-138-2-189-b27","series-title":"Best Pract Res Clin Gastroenterol","first-page":"227","article-title":"Evidence-based diagnosis and staging of pancreatic cancer","volume":"20","author":"Michl\n              P,","year":"2006","unstructured":"Michl\n              P, \n            \n              Pauls\n              S, \n            \n              Gress\n              TM. \n          \n          Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20(2):227\u2013251."},{"issue":"7","key":"i1543-2165-138-2-189-b28","series-title":"J Clin Endocrinol Metab","first-page":"1911","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick\n              MF,","year":"2011","unstructured":"Holick\n              MF, \n            \n              Binkley\n              NC, \n            \n              Bischoff-Ferrari\n              HA, \n            et al\n          . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911\u20131930."},{"issue":"1020","key":"i1543-2165-138-2-189-b29","series-title":"Postgrad Med J","first-page":"608","article-title":"The cure of ageing: vitamin D\u2014magic or myth?","volume":"86","author":"Chu\n              MP,","year":"2010","unstructured":"Chu\n              MP, \n            \n              Alagiakrishnan\n              K, \n            \n              Sadowski\n              C. \n          \n          The cure of ageing: vitamin D\u2014magic or myth?\n          Postgrad Med J. 2010;86(1020):608\u2013616."},{"issue":"1","key":"i1543-2165-138-2-189-b30","series-title":"Curr Drug Targets","first-page":"54","article-title":"Vitamin D in atherosclerosis, vascular disease, and endothelial function","volume":"12","author":"Brewer\n              LC,","year":"2011","unstructured":"Brewer\n              LC, \n            \n              Michos\n              ED, \n            \n              Reis\n              JP. \n          \n          Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets. 2011;12(1):54\u201360."},{"issue":"RR-8","key":"i1543-2165-138-2-189-b31","series-title":"MMWR Recomm Rep","first-page":"1","article-title":"Centers for Disease Control and Prevention. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection","volume":"57","author":"Weinbaum\n              CM,","year":"2008","unstructured":"Weinbaum\n              CM, \n            \n              Williams\n              I, \n            \n              Mast\n              EE, \n            et al;\n          \n          Centers for Disease Control and Prevention. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1\u201320."},{"issue":"6","key":"i1543-2165-138-2-189-b32","series-title":"Clin Gastroenterol Hepatol","first-page":"666","article-title":"Chronic hepatitis B: current testing strategies","volume":"4","author":"Gish\n              RG,","year":"2006","unstructured":"Gish\n              RG, \n            \n              Locarnini\n              SA. \n          \n          Chronic hepatitis B: current testing strategies. Clin Gastroenterol Hepatol. 2006;4(6):666\u2013676."},{"issue":"RR-19","key":"i1543-2165-138-2-189-b33","series-title":"MMWR Recomm Rep","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease","volume":"47","year":"1998","unstructured":"Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1\u201339."},{"issue":"RR-4","key":"i1543-2165-138-2-189-b34","series-title":"MMWR Recomm Rep","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965","volume":"61","author":"Smith\n              BD,","year":"2012","unstructured":"Smith\n              BD, \n            \n              Morgan\n              RL, \n            \n              Beckett\n              GA, \n            et al\n          . Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965. MMWR Recomm Rep. 2012;61(RR-4):1\u201332."},{"issue":"6","key":"i1543-2165-138-2-189-b35","series-title":"Ann Intern Med","first-page":"465","article-title":"Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force","volume":"140","author":"Chou\n              R,","year":"2004","unstructured":"Chou\n              R, \n            \n              Clark\n              EC, \n            \n              Helfand\n              M. \n          \n          Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(6):465\u2013479."},{"issue":"1","key":"i1543-2165-138-2-189-b36","series-title":"Clin Lab Med","first-page":"311","article-title":"Lyme disease","volume":"30","author":"Murray\n              TS,","year":"2010","unstructured":"Murray\n              TS, \n            \n              Shapiro\n              ED. \n          \n          Lyme disease. Clin Lab Med. 2010;30(1):311\u2013328."},{"issue":"6","key":"i1543-2165-138-2-189-b37","series-title":"Anaerobe","first-page":"270","article-title":"Clostridium difficile testing algorithms: what is practical and feasible?","volume":"15","author":"Schmidt\n              ML,","year":"2009","unstructured":"Schmidt\n              ML, \n            \n              Gilligan\n              PH. \n          \n          Clostridium difficile testing algorithms: what is practical and feasible?\n          Anaerobe. 2009;15(6):270\u2013273."},{"issue":"3","key":"i1543-2165-138-2-189-b38","series-title":"J Postgrad Med","first-page":"194","article-title":"The utility of repeat enzyme immunoassay testing for the diagnosis of Clostridium difficile infection: a systematic review of the literature","volume":"58","author":"Garimella\n              PS,","year":"2012","unstructured":"Garimella\n              PS, \n            \n              Agarwal\n              R, \n            \n              Katz\n              A. \n          \n          The utility of repeat enzyme immunoassay testing for the diagnosis of Clostridium difficile infection: a systematic review of the literature. J Postgrad Med. 2012;58(3):194\u2013198."},{"issue":"1","key":"i1543-2165-138-2-189-b39","series-title":"Mayo Clin Proc","first-page":"66","article-title":"Urine drug screening: practical guide for clinicians","volume":"83","author":"Moeller\n              KE,","year":"2008","unstructured":"Moeller\n              KE, \n            \n              Lee\n              KC, \n            \n              Kissack\n              JC. \n          \n          Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83(1):66\u201376."},{"issue":"7520","key":"i1543-2165-138-2-189-b40","series-title":"BMJ","first-page":"810","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster\n              AC,","year":"2005","unstructured":"Webster\n              AC, \n            \n              Woodroffe\n              RC, \n            \n              Taylor\n              RS, \n            \n              Chapman\n              JR, \n            \n              Craig\n              JC. \n          \n          Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ. 2005;331(7520):810."},{"issue":"7191","key":"i1543-2165-138-2-189-b41","series-title":"BMJ","first-page":"1104","article-title":"Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials","volume":"318","author":"Knoll\n              GA,","year":"1999","unstructured":"Knoll\n              GA, \n            \n              Bell\n              RC. \n          \n          Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ. 1999;318(7191):1104\u20131107."},{"issue":"suppl 2","key":"i1543-2165-138-2-189-b42","series-title":"J Psychopharmacol","first-page":"17","article-title":"Lithium in maintenance therapy for bipolar disorder","volume":"20","author":"Young\n              AH,","year":"2006","unstructured":"Young\n              AH, \n            \n              Newham\n              JI. \n          \n          Lithium in maintenance therapy for bipolar disorder. J Psychopharmacol. 2006;20(suppl 2):17\u201322."},{"issue":"3","key":"i1543-2165-138-2-189-b43","series-title":"Eur Arch Psychiatry Clin Neurosci","first-page":"132","article-title":"Lithium augmentation therapy in refractory depression-update 2002","volume":"253","author":"Bauer\n              M,","year":"2003","unstructured":"Bauer\n              M, \n            \n              Forsthoff\n              A, \n            \n              Baethge\n              C, \n            et al\n          . Lithium augmentation therapy in refractory depression-update 2002. Eur Arch Psychiatry Clin Neurosci. 2003;253(3):132\u2013139."},{"issue":"3","key":"i1543-2165-138-2-189-b44","series-title":"Eur Arch Psychiatry Clin Neurosci","first-page":"115","article-title":"Lithium in the acute treatment of bipolar disorders\u2014a stocktaking","volume":"253","author":"Grunze\n              H.","year":"2003","unstructured":"Grunze\n              H. \n          \n          Lithium in the acute treatment of bipolar disorders\u2014a stocktaking. Eur Arch Psychiatry Clin Neurosci. 2003;253(3):115\u2013119."},{"issue":"2\u20133","key":"i1543-2165-138-2-189-b45","series-title":"J Affect Disord","first-page":"273","article-title":"Trends in lithium prescription in Spain from 1985 to 2003","volume":"91","author":"Castells\n              X,","year":"2006","unstructured":"Castells\n              X, \n            \n              Vallano\n              A, \n            \n              Rigau\n              D, \n            \n              Perez\n              J, \n            \n              Casas\n              M, \n            \n              Capella\n              D. \n          \n          Trends in lithium prescription in Spain from 1985 to 2003. J Affect Disord. 2006;91(2\u20133):273\u2013276."},{"issue":"6","key":"i1543-2165-138-2-189-b46","series-title":"Acta Neurol Scand","first-page":"405","article-title":"Trends in utilization of antiepileptic drugs in Denmark","volume":"113","author":"Tsiropoulos\n              I,","year":"2006","unstructured":"Tsiropoulos\n              I, \n            \n              Gichangi\n              A, \n            \n              Andersen\n              M, \n            \n              Bjerrum\n              L, \n            \n              Gaist\n              D, \n            \n              Hallas\n              J. \n          \n          Trends in utilization of antiepileptic drugs in Denmark. Acta Neurol Scand. 2006;113(6):405\u2013411."},{"issue":"1","key":"i1543-2165-138-2-189-b47","series-title":"Clin Pharmacol Ther","first-page":"90","article-title":"Declining public health burden of digoxin toxicity from 1991 to 2004","volume":"84","author":"Haynes\n              K,","year":"2008","unstructured":"Haynes\n              K, \n            \n              Heitjan\n              D, \n            \n              Kanetsky\n              P, \n            \n              Hennessy\n              S. \n          \n          Declining public health burden of digoxin toxicity from 1991 to 2004. Clin Pharmacol Ther. 2008;84(1):90\u201394."},{"issue":"10","key":"i1543-2165-138-2-189-b48","series-title":"J Am Acad Child Adolesc Psychiatry","first-page":"1001","article-title":"National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996\u20132007","volume":"49","author":"Comer\n              JS,","year":"2010","unstructured":"Comer\n              JS, \n            \n              Olfson\n              M, \n            \n              Mojtabai\n              R. \n          \n          National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996\u20132007. J Am Acad Child Adolesc Psychiatry. 2010;49(10):1001\u20131010."},{"issue":"6","key":"i1543-2165-138-2-189-b49","series-title":"Arch Dis Child","first-page":"443","article-title":"Changing trends in antiepileptic drug prescribing in girls of child-bearing potential","volume":"94","author":"Ackers\n              R,","year":"2009","unstructured":"Ackers\n              R, \n            \n              Besag\n              FM, \n            \n              Wade\n              A, \n            \n              Murray\n              ML, \n            \n              Wong\n              IC. \n          \n          Changing trends in antiepileptic drug prescribing in girls of child-bearing potential. Arch Dis Child. 2009;94(6):443\u2013447."},{"issue":"22, pt 2","key":"i1543-2165-138-2-189-b50","series-title":"Neurology","first-page":"2171","article-title":"Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000\u20132004","volume":"70","author":"Pugh\n              MJ,","year":"2008","unstructured":"Pugh\n              MJ, \n            \n              Van Cott\n              AC, \n            \n              Cramer\n              JA, \n            et al\n          . Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000\u20132004. Neurology. 2008;70(22, pt 2):2171\u20132178."},{"issue":"6","key":"i1543-2165-138-2-189-b51","series-title":"Seizure","first-page":"466","article-title":"Trends in antiepileptic drug utilisation in UK primary care 1993\u20132008: cohort study using the General Practice Research Database","volume":"21","author":"Nicholas\n              JM,","year":"2012","unstructured":"Nicholas\n              JM, \n            \n              Ridsdale\n              L, \n            \n              Richardson\n              MP, \n            \n              Ashworth\n              M, \n            \n              Gulliford\n              MC. \n          \n          Trends in antiepileptic drug utilisation in UK primary care 1993\u20132008: cohort study using the General Practice Research Database. Seizure. 2012;21(6):466\u2013470."},{"issue":"34","key":"i1543-2165-138-2-189-b52","series-title":"BMC Med","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-34","article-title":"Biomarkers in acute myocardial infarction","volume":"8","author":"Chan\n              D,","year":"2010","unstructured":"Chan\n              D, \n            \n              Ng\n              LL. \n          \n          Biomarkers in acute myocardial infarction. BMC Med. 2010;8:34. doi:10.1186\/1741-7015-8-34."},{"issue":"3","key":"i1543-2165-138-2-189-b53","series-title":"J Cardiol","first-page":"317","article-title":"Inflammatory biomarkers in coronary artery disease","volume":"53","author":"Zakynthinos\n              E,","year":"2009","unstructured":"Zakynthinos\n              E, \n            \n              Pappa\n              N. \n          \n          Inflammatory biomarkers in coronary artery disease. J Cardiol. 2009;53(3):317\u2013333."},{"issue":"4","key":"i1543-2165-138-2-189-b54","series-title":"Ther Adv Cardiovasc Dis","first-page":"309","article-title":"The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease","volume":"3","author":"Kones\n              R.","year":"2009","unstructured":"Kones\n              R. \n          \n          The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease. Ther Adv Cardiovasc Dis. 2009;3(4):309\u2013315."},{"issue":"1","key":"i1543-2165-138-2-189-b55","series-title":"Cardiovasc Pathol","first-page":"14","article-title":"C-reactive protein: a nontraditional serum marker of cardiovascular risk","volume":"16","author":"de Ferranti\n              SD,","year":"2007","unstructured":"de Ferranti\n              SD, \n            \n              Rifai\n              N. \n          \n          C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol. 2007;16(1):14\u201321."},{"issue":"2","key":"i1543-2165-138-2-189-b56","series-title":"Curr Atheroscler Rep","first-page":"154","article-title":"The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial","volume":"13","author":"Abd\n              TT,","year":"2011","unstructured":"Abd\n              TT, \n            \n              Eapen\n              DJ, \n            \n              Bajpai\n              A, \n            \n              Goyal\n              A, \n            \n              Dollar\n              A, \n            \n              Sperling\n              L. \n          \n          The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial. Curr Atheroscler Rep. 2011;13(2):154\u2013161."},{"issue":"4","key":"i1543-2165-138-2-189-b57","series-title":"Clin Cardiol","first-page":"190","article-title":"Should we measure C-reactive protein on earth or just on JUPITER?","volume":"33","author":"Bajpai\n              A,","year":"2010","unstructured":"Bajpai\n              A, \n            \n              Goyal\n              A, \n            \n              Sperling\n              L. \n          \n          Should we measure C-reactive protein on earth or just on JUPITER?\n          Clin Cardiol. 2010;33(4):190\u2013198."},{"issue":"4","key":"i1543-2165-138-2-189-b58","series-title":"AACN Clin Issues","first-page":"520","article-title":"The measurement of brain natriuretic peptide in heart failure: precision, accuracy, and implications for practice","volume":"14","author":"Howie\n              JN,","year":"2003","unstructured":"Howie\n              JN, \n            \n              Caldwell\n              MA, \n            \n              Dracup\n              K. \n          \n          The measurement of brain natriuretic peptide in heart failure: precision, accuracy, and implications for practice. AACN Clin Issues. 2003;14(4):520\u2013531."},{"issue":"4","key":"i1543-2165-138-2-189-b59","series-title":"Heart Fail Rev","first-page":"349","article-title":"The role of brain natriuretic peptide in population screening","volume":"8","author":"Dyrbye\n              LN,","year":"2003","unstructured":"Dyrbye\n              LN, \n            \n              Redfield\n              MM. \n          \n          The role of brain natriuretic peptide in population screening. Heart Fail Rev. 2003;8(4):349\u2013354."},{"issue":"4","key":"i1543-2165-138-2-189-b60","series-title":"Heart Fail Rev","first-page":"327","article-title":"The diagnosis of acute congestive heart failure: role of BNP measurements","volume":"8","author":"Maisel\n              AS.","year":"2003","unstructured":"Maisel\n              AS. \n          \n          The diagnosis of acute congestive heart failure: role of BNP measurements. Heart Fail Rev. 2003;8(4):327\u2013334."},{"issue":"4\u20135","key":"i1543-2165-138-2-189-b61","series-title":"Clin Biochem","first-page":"227","article-title":"Evaluating the evidence for assessing BNP and NT-proBNP levels","volume":"41","author":"Busse\n              JW,","year":"2008","unstructured":"Busse\n              JW, \n            \n              Bassler\n              D, \n            \n              Guyatt\n              GH. \n          \n          Evaluating the evidence for assessing BNP and NT-proBNP levels. Clin Biochem. 2008;41(4\u20135):227\u2013330."},{"issue":"4\u20135","key":"i1543-2165-138-2-189-b62","series-title":"Clin Biochem","first-page":"260","article-title":"A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease","volume":"41","author":"Oremus\n              M,","year":"2008","unstructured":"Oremus\n              M, \n            \n              Raina\n              PS, \n            \n              Santaguida\n              P, \n            et al\n          . A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clin Biochem. 2008;41(4\u20135):260\u2013265."},{"issue":"11","key":"i1543-2165-138-2-189-b63","series-title":"Clin Res Cardiol","first-page":"973","article-title":"Biomarkers: optimizing treatment guidance in heart failure","volume":"100","author":"Bohm\n              M,","year":"2011","unstructured":"Bohm\n              M, \n            \n              Voors\n              AA, \n            \n              Ketelslegers\n              JM, \n            et al\n          . Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol. 2011;100(11):973\u2013981."},{"issue":"12","key":"i1543-2165-138-2-189-b64","series-title":"Heart","first-page":"959","article-title":"Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis","volume":"97","author":"Kelder\n              JC,","year":"2011","unstructured":"Kelder\n              JC, \n            \n              Cowie\n              MR, \n            \n              McDonagh\n              TA, \n            et al\n          . Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis. Heart. 2011;97(12):959\u2013963."},{"issue":"2","key":"i1543-2165-138-2-189-b65","series-title":"Intern Med J","first-page":"101","article-title":"Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction","volume":"38","author":"Ewald\n              B,","year":"2008","unstructured":"Ewald\n              B, \n            \n              Ewald\n              D, \n            \n              Thakkinstian\n              A, \n            \n              Attia\n              J. \n          \n          Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction. Intern Med J. 2008;38(2):101\u2013113."},{"issue":"4\u20135","key":"i1543-2165-138-2-189-b66","series-title":"Clin Biochem","first-page":"240","article-title":"Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care","volume":"41","author":"Hill\n              SA,","year":"2008","unstructured":"Hill\n              SA, \n            \n              Balion\n              CM, \n            \n              Santaguida\n              P, \n            et al\n          . Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care. Clin Biochem. 2008;41(4\u20135):240\u2013249."},{"issue":"142","key":"i1543-2165-138-2-189-b67","series-title":"Evid Rep Technol Assess (Full Rep)","first-page":"1","article-title":"Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure","author":"Balion\n              C,","year":"2006","unstructured":"Balion\n              C, \n            \n              Santaguida\n              PL, \n            \n              Hill\n              S, \n            et al\n          . Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Evid Rep Technol Assess (Full Rep). 2006;(142):1\u2013147."},{"issue":"6","key":"i1543-2165-138-2-189-b68","series-title":"J Am Acad Nurse Pract","first-page":"226","article-title":"Thyroid disease: a review for primary care","volume":"12","author":"Larson\n              J,","year":"2000","unstructured":"Larson\n              J, \n            \n              Anderson\n              EH, \n            \n              Koslawy\n              M. \n          \n          Thyroid disease: a review for primary care. J Am Acad Nurse Pract. 2000;12(6):226\u2013232."},{"key":"i1543-2165-138-2-189-b69","series-title":"Syst Evid Rev","article-title":"Screening for thyroid disease","volume":"23","author":"Helfand\n              M.","year":"2004","unstructured":"Helfand\n              M. \n          \n          Screening for thyroid disease. 2004. Syst Evid Rev. 23. http:\/\/www.ncbi.nlm.nih.gov\/books\/nbk42812. Accessed January 8, 2014."},{"issue":"2","key":"i1543-2165-138-2-189-b70","series-title":"JAMA","first-page":"228","article-title":"Subclinical thyroid disease: scientific review and guidelines for diagnosis and management","volume":"291","author":"Surks\n              MI,","year":"2004","unstructured":"Surks\n              MI, \n            \n              Ortiz\n              E, \n            \n              Daniels\n              GH, \n            et al\n          . Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228\u2013238."},{"issue":"6","key":"i1543-2165-138-2-189-b71","series-title":"Clin Neuropharmacol","first-page":"248","article-title":"Thyroid adverse effects of psychotropic drugs: a review","volume":"34","year":"2011","unstructured":"Bou Khalil R, Richa S. Thyroid adverse effects of psychotropic drugs: a review. Clin Neuropharmacol. 2011;34(6):248\u2013255."},{"issue":"1\u20132","key":"i1543-2165-138-2-189-b72","series-title":"Clin Chim Acta","first-page":"111","article-title":"Case finding and screening strategies for thyroid dysfunction","volume":"315","author":"Stockigt\n              JR.","year":"2002","unstructured":"Stockigt\n              JR. \n          \n          Case finding and screening strategies for thyroid dysfunction. Clin Chim Acta. 2002;315(1\u20132):111\u2013124."},{"issue":"3","key":"i1543-2165-138-2-189-b73","series-title":"Compr Ther","first-page":"202","article-title":"Cervical cancer screening from Pap smear to human papillomavirus DNA testing","volume":"27","author":"Jin\n              XW,","year":"2001","unstructured":"Jin\n              XW, \n            \n              Xu\n              H. \n          \n          Cervical cancer screening from Pap smear to human papillomavirus DNA testing. Compr Ther. 2001;27(3):202\u2013208."},{"issue":"1","key":"i1543-2165-138-2-189-b74","series-title":"Clin Microbiol Rev","first-page":"1","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd\n              EM.","year":"2003","unstructured":"Burd\n              EM. \n          \n          Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1\u201317."},{"issue":"2","key":"i1543-2165-138-2-189-b75","series-title":"Best Pract Res Clin Obstet Gynaecol","first-page":"209","article-title":"Human papillomavirus deoxyribonucleic acid testing in developed countries","volume":"26","author":"Bhatla\n              N,","year":"2012","unstructured":"Bhatla\n              N, \n            \n              Singla\n              S, \n            \n              Awasthi\n              D. \n          \n          Human papillomavirus deoxyribonucleic acid testing in developed countries. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):209\u2013220."},{"issue":"11","key":"i1543-2165-138-2-189-b76","series-title":"Clin Chem Lab Med","first-page":"1783","article-title":"Human papilloma virus (HPV) molecular diagnostics","volume":"49","author":"Kroupis\n              C,","year":"2011","unstructured":"Kroupis\n              C, \n            \n              Vourlidis\n              N. \n          \n          Human papilloma virus (HPV) molecular diagnostics. Clin Chem Lab Med. 2011;49(11):1783\u20131799."},{"issue":"4","key":"i1543-2165-138-2-189-b77","series-title":"Cancer Cytopathol","first-page":"219","article-title":"Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology","volume":"119","author":"Nishino\n              HT,","year":"2011","unstructured":"Nishino\n              HT, \n            \n              Tambouret\n              RH, \n            \n              Wilbur\n              DC. \n          \n          Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology. Cancer Cytopathol. 2011;119(4):219\u2013227."},{"issue":"1","key":"i1543-2165-138-2-189-b78","series-title":"Eur J Cancer Prev","first-page":"73","article-title":"Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30: systematic review","volume":"21","author":"Rebolj\n              M,","year":"2012","unstructured":"Rebolj\n              M, \n            \n              Njor\n              SH, \n            \n              Lynge\n              E. \n          \n          Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30: systematic review. Eur J Cancer Prev. 2012;21(1):73\u201381."},{"issue":"3","key":"i1543-2165-138-2-189-b79","series-title":"Sex Health","first-page":"376","article-title":"Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era","volume":"7","author":"Tota\n              J,","year":"2010","unstructured":"Tota\n              J, \n            \n              Mahmud\n              SM, \n            \n              Ferenczy\n              A, \n            \n              Coutlee\n              F, \n            \n              Franco\n              EL. \n          \n          Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era. Sex Health. 2010;7(3):376\u2013382."},{"issue":"2","key":"i1543-2165-138-2-189-b80","series-title":"Curr Gastroenterol Rep","first-page":"131","article-title":"New developments in pancreatic cancer","volume":"13","author":"Greer\n              JB,","year":"2011","unstructured":"Greer\n              JB, \n            \n              Brand\n              RE. \n          \n          New developments in pancreatic cancer. Curr Gastroenterol Rep. 2011;13(2):131\u2013139."},{"issue":"4\u20135","key":"i1543-2165-138-2-189-b81","series-title":"Dig Dis","first-page":"679","article-title":"What's new in therapy of pancreatic cancer?","volume":"28","author":"Mossner\n              J.","year":"2010","unstructured":"Mossner\n              J. \n          \n          What's new in therapy of pancreatic cancer?\n          Dig Dis. 2010;28(4\u20135):679\u2013683."},{"issue":"4","key":"i1543-2165-138-2-189-b82","series-title":"Oncology","first-page":"255","article-title":"Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer","volume":"70","author":"Boeck\n              S,","year":"2006","unstructured":"Boeck\n              S, \n            \n              Stieber\n              P, \n            \n              Holdenrieder\n              S, \n            \n              Wilkowski\n              R, \n            \n              Heinemann\n              V. \n          \n          Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer. Oncology. 2006;70(4):255\u2013264."},{"issue":"6","key":"i1543-2165-138-2-189-b83","series-title":"JOP","first-page":"536","article-title":"Molecular and clinical markers of pancreas cancer","volume":"11","author":"Buxbaum\n              JL,","year":"2010","unstructured":"Buxbaum\n              JL, \n            \n              Eloubeidi\n              MA. \n          \n          Molecular and clinical markers of pancreas cancer. JOP. 2010;11(6):536\u2013544."},{"issue":"6","key":"i1543-2165-138-2-189-b84","series-title":"Langenbecks Arch Surg","first-page":"883","article-title":"Molecular markers of pancreatic cancer: development and clinical relevance","volume":"393","author":"Fry\n              LC,","year":"2008","unstructured":"Fry\n              LC, \n            \n              Monkemuller\n              K, \n            \n              Malfertheiner\n              P. \n          \n          Molecular markers of pancreatic cancer: development and clinical relevance. Langenbecks Arch Surg. 2008;393(6):883\u2013890."},{"key":"i1543-2165-138-2-189-b85","article-title":"Surveillance, epidemiology and end results: cancer of pancreas. 2012","unstructured":"National Cancer Institute. Surveillance, epidemiology and end results: cancer of pancreas. 2012. http:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html#prevalence. Accessed January 8, 2014."},{"issue":"1","key":"i1543-2165-138-2-189-b86","series-title":"J Clin Endocrinol Metab","first-page":"53","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross\n              AC,","year":"2011","unstructured":"Ross\n              AC, \n            \n              Manson\n              JE, \n            \n              Abrams\n              SA, \n            et al\n          . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53\u201358."},{"issue":"suppl 5","key":"i1543-2165-138-2-189-b87","series-title":"Hepatology","first-page":"S35","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection","volume":"49","author":"Weinbaum\n              CM,","year":"2009","unstructured":"Weinbaum\n              CM, \n            \n              Mast\n              EE, \n            \n              Ward\n              JW. \n          \n          Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology. 2009;49(suppl 5):S35\u2013S44."},{"issue":"suppl 1","key":"i1543-2165-138-2-189-b88","series-title":"Clin Infect Dis","first-page":"S49","article-title":"Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update","volume":"55","author":"Smith\n              BD,","year":"2012","unstructured":"Smith\n              BD, \n            \n              Jorgensen\n              C, \n            \n              Zibbell\n              JE, \n            \n              Beckett\n              GA. \n          \n          Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update. Clin Infect Dis. 2012;55(suppl 1):S49\u2013S53."},{"issue":"11","key":"i1543-2165-138-2-189-b89","series-title":"Am Fam Physician","first-page":"1351","article-title":"Hepatitis C: diagnosis and treatment","volume":"81","author":"Wilkins\n              T,","year":"2010","unstructured":"Wilkins\n              T, \n            \n              Malcolm\n              JK, \n            \n              Raina\n              D, \n            \n              Schade\n              RR. \n          \n          Hepatitis C: diagnosis and treatment. Am Fam Physician. 2010;81(11):1351\u20131357."},{"key":"i1543-2165-138-2-189-b90","article-title":"Lyme disease data. 2012","unstructured":"Centers for Disease Control and Prevention. Lyme disease data. 2012. http:\/\/www.cdc.gov\/lyme\/stats\/index.html?utm_source=publish2&utm_medium=referral&utm_campaign=www.kpbs.org. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b91","article-title":"Influenza\u2014United States surveillance data: 1997\u20131998 through 2009\u20132010 seasons. 2010","unstructured":"Centers for Disease Control and Prevention. Influenza\u2014United States surveillance data: 1997\u20131998 through 2009\u20132010 seasons. 2010. http:\/\/www.cdc.gov\/flu\/weekly\/ussurvdata.htm. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b92","series-title":"Cochrane Database Syst Rev","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003961.pub2","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients","author":"Webster\n              A,","year":"2005","unstructured":"Webster\n              A, \n            \n              Woodroffe\n              RC, \n            \n              Taylor\n              RS, \n            \n              Chapman\n              JR, \n            \n              Craig\n              JC. \n          \n          Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev. 2005;(4):CD003961. doi: 10.1002\/14651858.CD003961.pub2."},{"issue":"1","key":"i1543-2165-138-2-189-b93","series-title":"Arch Intern Med","first-page":"55","article-title":"Stafford RS, Ruskin JN, Singer DE. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation","volume":"164","author":"Fang\n              MC,","year":"2004","unstructured":"Fang\n              MC, \n          \n          Stafford RS, Ruskin JN, Singer DE. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med. 2004;164(1):55\u201360."},{"issue":"71","key":"i1543-2165-138-2-189-b94","series-title":"Fed Regist","first-page":"19644","article-title":"Mandatory guidelines and proposed revisions to mandatory guidelines for federal workplace drug testing programs; notices","volume":"69","year":"2004","unstructured":"Department of Health and Human Services. Mandatory guidelines and proposed revisions to mandatory guidelines for federal workplace drug testing programs; notices. Fed Regist. 2004;69(71):19644\u201319673."},{"issue":"83","key":"i1543-2165-138-2-189-b95","series-title":"Fed Regist","first-page":"22809","article-title":"Mandatory guidelines for federal workplace drug testing programs","volume":"75","year":"2010","unstructured":"Department of Health and Human Services. Mandatory guidelines for federal workplace drug testing programs. Fed Regist. 2010;75(83):22809\u201322810."},{"key":"i1543-2165-138-2-189-b96","article-title":"Guidelines. 2012","unstructured":"American Society of Interventional Pain Physicians. Guidelines. 2012. http:\/\/www.asipp.org\/Guidelines.htm. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b97","article-title":"Interagency guideline on opioid dosing for non-cancer pain: an educational aid to improve care and safety with opioid therapy. 2010","unstructured":"Agency Medical Doctors Group. Interagency guideline on opioid dosing for non-cancer pain: an educational aid to improve care and safety with opioid therapy. 2010. http:\/\/www.agencymeddirectors.wa.gov\/files\/opioidgdline.pdf. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b98","article-title":"Prescription painkiller overdoses","unstructured":"Centers for Disease Control and Prevention. Prescription painkiller overdoses. http:\/\/www.cdc.gov\/vitalsigns\/methadoneoverdoses. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b99","article-title":"National Center for Injury Prevention and Control program report","year":"2012","unstructured":"Centers for Disease Control and Prevention. National Center for Injury Prevention and Control program report. 2012."},{"key":"i1543-2165-138-2-189-b100","series-title":"CAP Today","article-title":"Probing the nuances of pain management","author":"Lusky\n              K.","unstructured":"Lusky\n              K. \n          \n          Probing the nuances of pain management. CAP Today. April 2009.http:\/\/www.cap.org\/apps\/cap.portal?_nfpb=true&cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&_windowLabel=cntvwrPtlt&cntvwrPtlt%7BactionForm.contentReference%7D=cap_today%2F0409%2F0409b_pain_management.html&_state=maximized&_pageLabel=cntvwr. Accessed January 8, 2014."},{"issue":"3","key":"i1543-2165-138-2-189-b101","series-title":"J Pain Symptom Manage","first-page":"260","article-title":"Urine drug testing in pain medicine","volume":"27","author":"Heit\n              HA,","year":"2004","unstructured":"Heit\n              HA, \n            \n              Gourlay\n              DL. \n          \n          Urine drug testing in pain medicine. J Pain Symptom Manage. 2004;27(3):260\u2013267."},{"issue":"1","key":"i1543-2165-138-2-189-b102","series-title":"Pain Physician","first-page":"57","article-title":"Does adherence monitoring reduce controlled substance abuse in chronic pain patients?","volume":"9","author":"Manchikanti\n              L,","year":"2006","unstructured":"Manchikanti\n              L, \n            \n              Manchukonda\n              R, \n            \n              Damron\n              KS, \n            \n              Brandon\n              D, \n            \n              McManus\n              CD, \n            \n              Cash\n              K. \n          \n          Does adherence monitoring reduce controlled substance abuse in chronic pain patients?\n          Pain Physician. 2006;9(1):57\u201360."},{"key":"i1543-2165-138-2-189-b103","article-title":"Urine drug testing and monitoring in pain management. 2006","author":"Fornari\n              FA,","unstructured":"Fornari\n              FA, \n            \n              Siwicki\n              DM, \n            \n              Bauer\n              GB. \n          \n          Urine drug testing and monitoring in pain management. 2006. https:\/\/www.dominiondiagnostics.com\/docs\/pubs\/0607DominionPub_UDTinPainManagement.pdf. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b104","article-title":"Drug abuse warning network, 2009: national estimates of drug-related emergency department visits","year":"2011","unstructured":"Substance Abuse and Mental Health Services Administration. Drug abuse warning network, 2009: national estimates of drug-related emergency department visits. 2011. http:\/\/www.samhsa.gov\/data\/2k11\/dawn\/2k9dawned\/html\/dawn2k9ed.htm. Accessed January 8, 2014."},{"key":"i1543-2165-138-2-189-b105","article-title":"2012. Part B: national summary data file (previously known as BESS)","unstructured":"Centers for Medicare & Medicaid Services. 2012. Part B: national summary data file (previously known as BESS). http:\/\/www.cms.gov\/research-statistics-data-and-systems\/files-for-order\/nonIdentifiabledatafiles\/partbnationalsummarydatafile.html. Accessed January 8, 2014."}],"container-title":["Archives of Pathology and Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/138\/2\/article-p189.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/138\/2\/189\/2271146\/arpa_2013-0149-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/138\/2\/article-p189.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/138\/2\/article-p189.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:00:56Z","timestamp":1770771656000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/138\/2\/article-p189.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":210,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2013-0149-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}